戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 omen affected by this condition during their reproductive years.
2  diagnosed and start medication during their reproductive years.
3 en as compared with men, specifically during reproductive years.
4  risk factors for CVD present during women's reproductive years.
5 tes use hormonal contraceptives during their reproductive years.
6 ber of women with an HDP history after their reproductive years.
7 erely by lengthening women's total number of reproductive years.
8 ammatory disease that affects women in their reproductive years.
9 and body size similarly avoid cancer through reproductive years.
10  common disease affecting women during their reproductive years.
11 ffecting approximately 10% of women in their reproductive years.
12 ven among low-income minority women in their reproductive years.
13  women at risk for episodes throughout their reproductive years.
14 ecting significant numbers of women in their reproductive years.
15 cer patients treated with this drug in their reproductive years.
16 ch is typically diagnosed during a patient's reproductive years.
17 effect on ovarian hormones during the middle reproductive years.
18 terine bleeding (AUB) at some point in their reproductive years.
19 dwide, and 9 million women in the US, during reproductive years.
20 tillbirths, number of live births, and total reproductive years.
21  in women than in men, especially during the reproductive years.
22  risk, and a higher prevalence occurs during reproductive years.
23 ulted in a 6-year reduction in the number of reproductive years (30.0, 37.0, and 35.2 years, respecti
24 fertility with patients treated during their reproductive years and be prepared to discuss possible f
25 vention of cardiovascular disease during the reproductive years and beyond.
26  as the number of weaned calves produced per reproductive years and calf survival at year one and thr
27 emales, oxytocin levels were high during the reproductive years and declined in the early to midforti
28 Tuberculosis is most common during a woman's reproductive years and is a major cause of maternal-chil
29 me of the healthy female human breast during reproductive years and provide evidence of how parity af
30  factors identified among women during their reproductive years and their importance in lifetime risk
31 ease (IBD) often affects women in their peak reproductive years, and therapy is often continued durin
32 les that are neutral to selection until post-reproductive years are influenced by random genetic drif
33 tions of weight trajectories during females' reproductive years, before and between pregnancies, with
34 d adaptations that optimize survival through reproductive years can become maladaptive with aging, re
35                The overlap of residency with reproductive years creates significant challenges for th
36 nce medical training often overlaps with key reproductive years for female physicians, many women hav
37 ing that women in the United States in their reproductive years have experienced increased drinking o
38 orders in women and their early onset during reproductive years have implicated female sex hormones,
39                                       During reproductive years (i.e., after puberty and prior to men
40 mmune disease that usually occurs during the reproductive years in both sexes.
41 success with trends beginning in their early reproductive years, increased risk for producing offspri
42 nstrated a woman's burden of risk during her reproductive years is associated with future risk of CVD
43 nopause, which resulted in a 17% decrease in reproductive years, is a major unstudied complication of
44 in anxiety disorders in females during their reproductive years, it is important to understand whethe
45 ace and distal fallopian tube over a woman's reproductive years may increase ovarian cancer risk.
46                               During women's reproductive years, migraine is three times more common
47                           Longer duration of reproductive years of life and thus greater exposure to
48                                    Length of reproductive years of life, computed as the difference b
49 fertility with patients treated during their reproductive years (or with parents or guardians of chil
50 men with RP are often diagnosed during their reproductive years, posing significant challenges for fa
51 bserved an increase in the average number of reproductive years (subtracting age at menarche from age
52 suggesting a phenotype observable during the reproductive years that may allow clinicians to target w
53                  Each month during a woman's reproductive years, the endometrium undergoes vast chang
54 esult, a growing number of women enter their reproductive years treated with medication for ADHD or a
55                                    Length of reproductive years was also inversely associated with th
56 fects women (3:1 ratio), particularly during reproductive years, with sex hormones and X-linked genes
57                                 During their reproductive years, women have a much lower incidence of